World Parliament Act on Global Standards for Ethical Human Experimentation

World Parliament Act on Global Standards for Ethical Human Experimentation

Preamble

Recognizing the profound potential of scientific research involving human participants to advance health, knowledge, and well-being, and acknowledging the imperative to safeguard the rights, dignity, and welfare of all individuals, the World Parliament hereby establishes a universal framework for ethical human experimentation. This Act seeks to harmonize national and international practices, fostering an environment of trust, responsibility, and scientific integrity across the globe.

Article I: Definitions

For the purposes of this Act:

1. "Human Experimentation" or "Research involving Human Participants" refers to any systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge, which involves living individuals about whom an investigator obtains data through intervention or interaction with the individual, or identifiable private information.
2. "Participant" refers to any individual who is a subject of human experimentation.
3. "Informed Consent" means a participant's voluntary agreement to participate in research, given with adequate knowledge of the nature, purpose, risks, benefits, alternatives, and implications of the research.
4. "Ethics Review Committee (ERC)" or "Institutional Review Board (IRB)" refers to an independent body constituted of medical, scientific, and non-scientific members, whose responsibility is to ensure the protection of the rights, safety, and well-being of human participants involved in a study.
5. "Vulnerable Populations" refers to individuals or groups who may have an impeded ability to protect their own interests, including, but not limited to, children, prisoners, pregnant women, persons with impaired decision-making capacity, economically disadvantaged persons, and persons in dependent relationships.

Article II: Core Ethical Principles

All human experimentation shall adhere to the following fundamental principles:

Section 1: Respect for Persons

a. Informed Consent: Research shall be conducted only with the free, prior, and informed consent of the participant. Consent must be documented, comprehensible, and allow for voluntary withdrawal at any time without penalty. For individuals lacking the capacity to provide consent, legally authorized representatives shall provide consent, with the participant's assent sought wherever possible.
b. Autonomy: Participants' decisions regarding their participation shall be respected, and their privacy and confidentiality protected to the maximum extent possible.

Section 2: Beneficence

a. Risk-Benefit Assessment: Research must be designed to maximize potential benefits to participants and society while minimizing risks to participants. The potential benefits must justify the foreseeable risks.
b. Competent Research Design: Research must be scientifically sound, relevant, and designed to yield valuable knowledge that cannot be obtained by other means.

Section 3: Justice

a. Fair Selection: The selection of research participants must be equitable, ensuring that the burdens and benefits of research are distributed fairly across populations. Exploitation of vulnerable populations for research purposes is strictly prohibited.
b. Access to Benefits: Where research yields significant health benefits or successful interventions, reasonable and equitable access shall be considered for participants and relevant communities, particularly in resource-limited settings.

Article III: Independent Ethics Review

Section 1: Mandatory Review

All human experimentation, regardless of funding source or location, must undergo prior review and approval by an independent and duly constituted Ethics Review Committee (ERC) or Institutional Review Board (IRB) that is accredited or recognized by a national or international authority.

Section 2: Composition and Independence

a. ERCs/IRBs shall be multidisciplinary, comprising members with scientific, medical, ethical, and legal expertise, as well as community representation.
b. ERCs/IRBs shall operate independently from research sponsors, investigators, and institutions to avoid conflicts of interest.

c. ERCs/IRBs shall have the authority to approve, require modifications in (to secure approval), or disapprove all research activities covered by this Act.

Section 3: Continuing Review

ERCs/IRBs shall conduct continuing review of approved research at least annually, and more frequently if deemed necessary, to ensure ongoing adherence to ethical standards and safety protocols.

Article IV: Protections for Vulnerable Populations

Section 1: Justification for Inclusion

Research involving vulnerable populations is permissible only when the research question can only be addressed by their inclusion, and when specific additional safeguards are in place to protect their rights and welfare. The research must directly benefit the vulnerable population or address conditions disproportionately affecting them.

Section 2: Enhanced Consent Procedures

For vulnerable populations, specific procedures shall be implemented to ensure that consent or assent is truly voluntary and informed, including simplified language, involvement of trusted intermediaries, and independent advocacy where appropriate.

Article V: Research Integrity and Transparency

Section 1: Data Management and Reporting

a. Researchers shall ensure the accuracy, integrity, and confidentiality of research data.
b. Research findings, both positive and negative, shall be disseminated transparently and promptly, typically through peer-reviewed publications or public registries, to contribute to the global knowledge base and prevent unnecessary duplication of research.

Section 2: Conflict of Interest

All potential conflicts of interest relevant to the research must be disclosed by researchers, sponsors, and ERC/IRB members and appropriately managed or mitigated.

Article VI: Oversight and Enforcement

Section 1: National Implementation

Member States of the World Parliament shall establish or strengthen national legislative and regulatory frameworks to implement and enforce the provisions of this Act, including mechanisms for accreditation of ERCs/IRBs, investigation of ethical violations, and imposition of sanctions.

Section 2: International Cooperation

The World Parliament shall facilitate international cooperation in ethical review, mutual recognition of standards, and capacity building, particularly in low- and middle-income countries, to ensure a globally consistent level of ethical protection.

Section 3: Redress and Accountability

Mechanisms shall be established to provide appropriate redress for participants harmed as a direct result of their involvement in research, including access to medical care and compensation, without prejudice to fault.

Article VII: Final Provisions

Section 1: Review and Amendment

This Act shall be subject to periodic review by the World Parliament, at least every five years, to ensure its continued relevance and effectiveness in light of scientific advancements and evolving ethical considerations. Amendments may be proposed by any Member State and adopted by a majority vote of the World Parliament.

Section 2: Entry into Force

This Act shall enter into force six (6) months after its adoption by the World Parliament.